Diphtheria typically presents with a sore throat, fever, and swollen glands in the neck. The hallmark sign is a thick, gray membrane covering the throat and tonsils. In severe cases, it can lead to difficulty breathing, heart failure, paralysis, or even death. Some patients may also experience skin lesions, particularly in tropical regions.

Diagnosing diphtheria involves a combination of clinical evaluation and laboratory tests. A throat swab is taken to culture the bacteria and confirm the presence of Corynebacterium diphtheriae. Blood tests may also be conducted to assess the patient's overall health and check for complications. In some cases, a sample from a skin lesion may be tested.

The primary treatment for diphtheria is the administration of diphtheria antitoxin, which neutralizes the toxin produced by the bacteria. Antibiotics, such as penicillin or erythromycin, are also prescribed to eradicate the bacteria and prevent transmission. Supportive care, including maintaining an open airway and monitoring for complications, is crucial.

With prompt treatment, the prognosis for diphtheria is generally good. However, if left untreated, the disease can be fatal, with a mortality rate of up to 10%. Complications such as myocarditis (inflammation of the heart muscle) and neuropathy (nerve damage) can occur, leading to long-term health issues.

Diphtheria is caused by the bacterium Corynebacterium diphtheriae. The bacteria produce a toxin that damages tissues and organs, leading to the symptoms of the disease. Transmission occurs through respiratory droplets from coughing or sneezing, or through contact with contaminated objects or surfaces.

Diphtheria was once a major cause of illness and death worldwide but has become rare in countries with widespread vaccination programs. However, it remains a concern in areas with low vaccination coverage. Outbreaks can occur in regions with poor healthcare infrastructure or during humanitarian crises.

The pathophysiology of diphtheria involves the production of a potent toxin by Corynebacterium diphtheriae. This toxin inhibits protein synthesis in cells, leading to cell death and tissue damage. The formation of a pseudomembrane in the throat can obstruct the airway, while systemic absorption of the toxin can affect the heart, nerves, and other organs.

Diphtheria is preventable through vaccination. The diphtheria toxoid vaccine is part of the routine childhood immunization schedule and is often combined with vaccines for tetanus and pertussis (whooping cough) in the DTaP vaccine. Booster shots are recommended for adults to maintain immunity.

Corynebacterium diphtheriae is the bacterium responsible for diphtheria, a potentially life-threatening disease. It primarily affects the respiratory system but can have systemic effects. Early diagnosis and treatment with antitoxin and antibiotics are crucial for a favorable outcome. Vaccination remains the most effective means of prevention.

Diphtheria is a serious bacterial infection that can cause a thick coating in the throat, making it hard to breathe. It spreads through coughs and sneezes. Symptoms include sore throat, fever, and swollen neck glands. Treatment involves antitoxin and antibiotics. Vaccination is key to preventing diphtheria, so ensure you and your family are up to date with your shots.